MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'advanced cell technology'. Sat, 03 Sep 2011 02:59:55 +0100 http://www.medworm.com/index.php?rid=4372048&cid=t_157456_87_f&fid=39187&url=http%3A%2F%2Fgetbetterhealth.com%2Fsynthetic-blood-via-artificial-cells-and-platelets-from-stem-cells%2F2011.01.19 There’s hema­tology news, times two (at least): 1. Progress in devel­oping syn­thetic red blood cells A University of North Carolina-Chapel Hill research group has created hydrogel par­ticles that mimic the size, shape and flex­i­bility of red blood cells (RBCs). The researchers used PRINT® (Particle Replication in Non-wetting Templates) tech­nology to gen­erate the fake RBCs, which are said to have a rel­a­tively long half-life. The findings were reported on-line yes­terday in the Proceedings of the National Academy of Sciences (PNAS) (abstract available, sub­scription required for full text). According to a PR-ish but inter­esting post on Futurity, a website put forth by a con­sortium of major research uni­ver­sities, tests of the par­ticles’ ability to ... Better Health blogs http://www.medworm.com/rss/comments.php?id=4372048 Wed, 19 Jan 2011 14:00:47 +0100 4372048 http://www.medworm.com/index.php?rid=1655378&cid=t_157456_87_f&fid=34825&url=http%3A%2F%2Fwww.wesleyjsmith.com%2Fblog%2F2008%2F07%2Fend-of-line-for-advamced-cell.html I have been very critical of Advanced Cell Technology, believing it to be a publicity seeking enterprise that used press releases to raise venture capital for morally problematic research into human cloning, ESC, the like, while at the same time, it tried to manipulate the political system to create an environment that would be conducive to it receiving taxpayer dollars. But now, that strategy may have reached the point of exhaustion. The company is apparently on the verge of going out of business. From the story: In a Securities and Exchange Commission filing Tuesday, the company warned that it doesn't have cash to continue operating after July 31 without raising additional money or drastically slashing operations. It reported $17 million in current liabilities, but only $1 million in cas... Secondhand Smoke blogs http://www.medworm.com/rss/comments.php?id=1655378 Fri, 25 Jul 2008 04:32:00 +0100 1655378 http://www.medworm.com/index.php?rid=1652240&cid=t_157456_87_f&fid=34825&url=http%3A%2F%2Fwww.wesleyjsmith.com%2Fblog%2F2008%2F07%2Fend-of-line-for-advamced-cell.html I have been very critical of Advanced Cell Technology, believing it to be a publicity seeking enterprise that used press releases to raise venture capital for morally problematic research into human cloning, ESC, the like, while at the same time, it tried to manipulate the political system to create an environment that would be conducive to it receiving taxpayer dollars. But now, that strategy may have reached the point of exhaustion. The company is apparently on the verge of going out of business. From the story: In a Securities and Exchange Commission filing Tuesday, the company warned that it doesn't have cash to continue operating after July 31 without raising additional money or drastically slashing operations. It reported $17 million in current liabilities, but only $1 million in cas... Secondhand Smoke blogs http://www.medworm.com/rss/comments.php?id=1652240 Fri, 25 Jul 2008 04:32:00 +0100 1652240 http://www.medworm.com/index.php?rid=1041884&cid=t_157456_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F188255331%2F Despite excitement among some scientists - and at the White House - about an embryo-free technique for creating human stem cells, reaction from companies that might turn the research into treatments is subdued, the Associated Press reports. In two papers published yesterday, researchers reported successfully programming ordinary human skin cells to behave like embryonic stem cells, which can theoretically be transformed into a variety of human tissues. But while biotech execs say the announcement is scientifically interesting, they also add that the new technique is even less likely to yield meaningful results soon than using embryonic cells - which requires destroying embryos. One exec, whose company’s stem-cell treatments may soon enter human clinical trials, notes that the FDAS is... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1041884 Wed, 21 Nov 2007 12:33:21 +0100 1041884